ID   BCH-N-DR
AC   CVCL_B7KC
SY   Birmingham Children's Hospital-Neuroblastoma-DR
DR   CancerTools; 160623
DR   Wikidata; Q112929283
DR   Ximbio; 160623
RX   PubMed=11675134;
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=17506115; DOI=10.1002/nbm.1181;
RA   Peet, Andrew C.
RA   McConville, Carmel M.
RA   Wilson, Martin Paul
RA   Levine, Barry A.
RA   Reed, Michelle
RA   Dyer, Sara A.
RA   Edwards, Emma C.
RA   Strachan, Mary C.
RA   McMullan, Dominic J.
RA   Wilkes, Timothy M.
RA   Grundy, Richard G.
RT   "1H MRS identifies specific metabolite profiles associated with
RT   MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell
RT   lines.";
RL   NMR Biomed. 20:692-700(2007).
//
RX   PubMed=11675134; DOI=10.1016/S0165-4608(01)00480-0;
RA   McConville, Carmel M.
RA   Dyer, Sara A.
RA   Rees, Sally A.
RA   Oude Luttikhuis, Monique Elisabeth Maria
RA   McMullan, Dominic J.
RA   Vickers, Susan J.
RA   Ramani, Pramila
RA   Redfern, Darren
RA   Morland, Bruce J.
RT   "Molecular cytogenetic characterization of two non-MYCN amplified
RT   neuroblastoma cell lines with complex t(11;17).";
RL   Cancer Genet. Cytogenet. 130:133-140(2001).
//